SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056515
Filing Date
2021-11-12
Accepted
2021-11-12 08:35:16
Documents
70
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rxdx-10q_20210930.htm   iXBRL 10-Q 2527992
2 EX-10.2 rxdx-ex102_81.htm EX-10.2 100927
3 EX-31.1 rxdx-ex311_10.htm EX-31.1 19528
4 EX-31.2 rxdx-ex312_9.htm EX-31.2 19254
5 EX-32.1 rxdx-ex321_8.htm EX-32.1 10278
6 EX-32.2 rxdx-ex322_6.htm EX-32.2 10058
  Complete submission text file 0001564590-21-056515.txt   9133249

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20210930.xsd EX-101.SCH 71762
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxdx-20210930_cal.xml EX-101.CAL 49400
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxdx-20210930_def.xml EX-101.DEF 284210
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20210930_lab.xml EX-101.LAB 527245
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20210930_pre.xml EX-101.PRE 425834
12 EXTRACTED XBRL INSTANCE DOCUMENT rxdx-10q_20210930_htm.xml XML 1395464
Mailing Address 9410 CARROLL PARK DRIVE SAN DIEGO CA 92121
Business Address 9410 CARROLL PARK DRIVE SAN DIEGO CA 92121 (858) 200-7888
Prometheus Biosciences, Inc. (Filer) CIK: 0001718852 (see all company filings)

IRS No.: 814282653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40187 | Film No.: 211399968
SIC: 2834 Pharmaceutical Preparations